Research Article: Evaluation of the efficiency of nanomicellar formulation of fat-soluble vitamins in patients with cystic fibrosis: the study protocol for a randomized controlled trial
Introduction:
Cystic fibrosis (CF) is a life-shortening, autosomal recessive genetic disorder, and the most common inherited disease in Caucasians. The disease prognosis has improved considerably in recent decades with the advanced treatments, and the mortality rate has been reduced by 2% annually. The average age of survival in CF patients has been reported to be 65 years in men and 56 years in women [1]. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, resulting in impaired…
Read more